HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recanalization of arterial occlusions with a lensed fiber and a holmium:YAG laser.

Abstract
Laser recanalization of totally occluded swine iliac arteries was performed to assess the safety and efficacy of a lensed fiber laser angioplasty system with a holmium:YAG (2.1 microns) laser. Silica lenses of 1.0 mm, 1.3 mm, and 1.5 mm in diameter attached to the distal end of a 300-microns diameter silica fiber delivered fluences of 79.5 J/cm2, 31.4 J/cm2, and 25.5 J/cm2, respectively. The pulse duration of the laser was 250 microseconds and the repetition rate was 4 Hz. The mean length of the total occlusions was 5.3 +/- 2.0 cm (range 0.5 cm to 8.0 cm). Successful recanalization was obtained in 16/16 lesions without angiographic vessel perforation. Angiographically significant residual stenoses (greater than 50%) remained in every case following successful laser recanalization. Histologically there was minimal evidence of thermal or acoustic tissue injury; however, in 4 of 16 arteries there was evidence of deep arterial dissection following laser recanalization. We conclude that this lensed fiber coupled with a holmium:YAG laser is a safe and effective method for crossing total occlusions in the relatively straight iliac arteries of this animal model.
AuthorsC J White, S R Ramee, T J Collins, J E Mesa, D B Paulsen, J P Murgo
JournalLasers in surgery and medicine (Lasers Surg Med) Vol. 11 Issue 3 Pg. 250-6 ( 1991) ISSN: 0196-8092 [Print] United States
PMID1650412 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Silicon Dioxide
  • Holmium
Topics
  • Angioplasty, Laser (adverse effects, instrumentation)
  • Animals
  • Arteriosclerosis (surgery)
  • Female
  • Fiber Optic Technology
  • Holmium
  • Lenses
  • Male
  • Silicon Dioxide
  • Swine
  • Swine, Miniature

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: